Clinical trials: Enterovirus 71 Human
Enterovirus 71 Human
Long-Term Immunogenicity of Envacgen® in Children
This study is designed to evaluate the long-term antibody titers of Envacgen® approximately 6 years after the first vaccination dose in participants who were aged 2 months to <6 years at the time of enrollment in the CT-EV-31s…
- Trial name
- NCT07568522
- Testing
- EV71 vaccine
- Where
- 4 sites in Taiwan
- Volunteers
- 220 people, healthy volunteers welcome
- Sponsor
- Medigen Vaccine Biologics Corp.
Enterovirus 71 Human
Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children
This study is designed to evaluate the long-term antibody titers of EV71 vaccine 4 and 5 years after first dose vaccination for subjects at the age of 2 to < 6 years , and 3 to 5 years after first dose vaccination for subjects at…
- Trial name
- NCT04072276
- Testing
- EV71 vaccine
- Where
- 4 sites in Taiwan
- Volunteers
- 227 people, healthy volunteers welcome
- Sponsor
- Medigen Vaccine Biologics Corp.
Enterovirus 71 Human
A Clinical Study for Inactivated Vaccine Against EV71
This study aims to evaluate the safety, reactogenicity and immunogenicity of EV71 vaccine in health children and infants aged from 2 months to <12yrs.
- Trial name
- EV71 (NCT02200237)
- Testing
- EV71 with adjuvant aluminium phosphate
- Where
- 4 sites in Taiwan
- Volunteers
- 366 people, healthy volunteers welcome
- Sponsor
- Medigen Vaccine Biologics Corp.